_:nc306530e7ad747c6a2eaf4b2f917a306xb2
<http://schema.org/name>
"JAMA Oncology Publishes Results of Phase III Study for Prestige BioPharma’s HERCEPTIN Biosimilar, HD201"
<https://www.bigmoleculewatch.com/2022/03/21/jama-oncology-publishes-results-of-phase-iii-study-for-prestige-biopharmas-herceptin-biosimilar-hd201/>